Regenxbio (RGNX) Reports Q3 Loss of $1.52/Share

Regenxbio (NASDAQ: RGNX) reported Q3 EPS of ($1.52), versus ($0.73) reported last year. Revenue for the quarter came in at $1.1 million, versus $500 thousand reported last year.

For earnings history and earnings-related data on Regenxbio (RGNX) click here.

You May Also Be Interested In

• SanDisk and Micron surge as Apple confirms memory price pass-through
• Micron Technology (MU) PT Raised to $1,300 at Bernstein SocGen Group
• JPMorgan Downgrades Anima Holding SA (ANIM3:BZ) to Neutral